ArticleScientific reports2021

In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection.

Amirhossein Ahmadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.